Armata Pharmaceuticals's total assets for Q3 2025 were $89.52M, an increase of 10.80% from the previous quarter. ARMP total liabilities were $185.10M for the fiscal quarter, a 23.16% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.